Date	Article
13 Dec 2000	Oxford BioMedica Announces Collaboration Agreement with Valentis on its Cancer Therapeutic, MetXiaŽ
04 Dec 2000	New LentiVector® Transport Technology Developed with Possible Wide Applications For Neurological Diseases
06 Nov 2000	Oxford BioMedica Announces First Clinical Trial Results for its Cancer Therapeutic, MetXia®
16 Oct 2000	Oxford BioMedica Obtains Ethical Approval for TroVax™ to Enter Trials for Colorectal Cancer
26 Sep 2000	Oxford BioMedica Announces Bioinformatics Collaboration with Informax - Oxford BioMedica to be First Genomax™ User in UK
16 Aug 2000	Announcement of Results For The 6 Months Ended 30 June 2000
15 Aug 2000	Oxford BioMedica Presents Discovery of Novel Genes Relevant to Cancer, Heart Disease and Inflammatory Disease at Drug Discovery Conference
10 Aug 2000	Oxford BioMedica Raises £8.5 Million and Establishes a Gene Discovery Division
26 Jun 2000	Oxford BioMedica Announces Significant Advances in Gene Transfer to the Brain
06 Jun 2000	Oxford BioMedica Announces Collaboration Extension with Aventis Pharmaceuticals Inc. on Gene Therapy for Cardiovascular Disease
18 May 2000	Oxford BioMedica: Acquisition of Therapeutic Genes and Issue of Shares
02 May 2000	Oxford BioMedica Acquires Novel Therapeutic Genes for Treatment of Cancer and Other Diseases
21 Mar 2000	Oxford BioMedica Appointment of Commercial Director
20 Mar 2000	Oxford BioMedica Signs Deal with Nycomed Amersham Imaging
16 Mar 2000	Oxford BioMedica Comment on Human Genome/Patenting Issue
28 Feb 2000	Oxford BioMedica Obtains Gene Therapy Patent In The USA
24 Feb 2000	Announcement of Results For The Year Ended 31 December 1999
21 Feb 2000	Oxford BioMedica Signs Deal on Novel Tumour Vaccine
14 Feb 2000	Oxford BioMedica Announces Collaboration with AstraZeneca and the Establishment of a Drug Drug Discovery Unit
02 Feb 2000	Oxford BioMedica Annouces Successful Developments in MacroGen Cancer Therapy
24 Jan 2000	Response to Press Commentary on FDA Ruling on Philadelphia Gene Therapy Trials
20 Jan 2000	Oxford BioMedica and IDM Announce Strategic Colloboration to Develop New Cell-Based Therapy Programmes
17 Jan 2000	Oxford BioMedica Raises £5.0 million
07 Jan 2000	Oxford BioMedica Announces New Developments in Cancer Therapy

Website by College Hill - Life Sciences